Legal Representation
Attorney
Norm J. Rich and Michele M. Simkin
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 6, 2010 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 6, 2010 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 28, 2010 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | Loading... |
| May 27, 2010 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 4, 2010 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 22, 2010 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 4, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 2, 2009 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 2, 2009 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 2, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 5, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 10, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 21, 2009 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 7, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jan 7, 2009 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 22, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 22, 2008 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Dec 22, 2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 22, 2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 20, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 26, 2008 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| Sep 25, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Oral pharmaceutical preparations used for the buccal delivery of drugs, namely, disintregratable mouth soluble tablets in the nature of antacids, antispasmodics and anti-ulcerants, anti-diarrheals, colorectal agents, cardiac drugs, CNS stimulants, analgesics, antipyretics and anti-inflammatory agents, muscle relaxants, hormonal, enzymal and steroidal preparations, drugs affecting bone metabolism, drugs affecting the genito-urinary system, diuretics and anti-diuretics, anti-infectives, anti-virals and immunological agents, electrolytes, vitamins and anabolic agents, bronchodilators, anti-asthmatics, expectorants, anti-tussives, decongestants, mucolytics and respiratory stimulants, oropharyngeal, aural and ocular preparations, anti-allergic drugs, hyposensitizing preparations, local and general anesthetics, oral and transdermal contraceptives, medical diagnostic reagents, anti-sense, oglionucleatides, mucosal vaccines, gene-based medicines, permeability and enhancing agents, and for the treatment of disorders of the central nervous system, dermatological disorders, antineoplastic pharmaceutical preparations for inhibiting or preventing the growth and spread of neoplasms or malignant cells
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
DRY DOS
Classification
International Classes
005